Affinity Chromatography Ligand Leaching Prevention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Affinity chromatography faces challenges due to the labile nature of ligands coupled to a support as the stationary phase, leading to dissociation and contamination of purified species with leached ligands, which can impede the effectiveness of therapeutic agents and cause harm by recombining with biological components.
Innovation Solution
A stationary phase with at least two ligands is used, where the first ligand binds to the solute of interest and the second ligand selectively captures dissociated segments of the first ligand, preventing contamination by immobilizing them within the same separation medium, thereby serving both to isolate and purify the species of interest and remove contaminants.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Device complexity
If a single ligand is used for affinity binding, then the purification process is simple, but leached ligands contaminate the purified species
Solution Approach 1:
The patent combines two ligands with different functions into a single stationary phase: the first ligand for capturing the target species and the second ligand for capturing leached first ligand. This merging allows both purification and contamination prevention to occur simultaneously in one column, resolving the contradiction between process simplicity and contamination prevention.
Solution Approach 2:
The stationary phase is designed with multi-functionality by incorporating two ligands that perform different roles: the first ligand performs the primary purification function while the second ligand performs the contamination control function. This universal design allows the single stationary phase to address multiple problems that would otherwise require separate processing steps.
2Reliability
If ligands are coupled to support by covalent bonds, then the ligand is immobilized, but the linkage is labile and dissociation occurs during liquid passage
Solution Approach 1:
The patent applies preliminary anti-action by introducing the second ligand that specifically captures dissociated first ligand segments before they can contaminate the purified product. This preemptive measure counteracts the inevitable dissociation that occurs during liquid passage, maintaining system reliability despite linkage lability.
Solution Approach 2:
The patent converts the harmful effect of ligand dissociation into a beneficial outcome by using the second ligand to capture the dissociated segments. What would normally be contamination (harm) is instead redirected to a controlled capture mechanism (benefit), where the leached ligand is immobilized by the second ligand rather than contaminating the product.
3Object-affected harmful factors
If leached ligands are removed by downstream separations, then product purity is maintained, but cost and time increase
Solution Approach 1:
The patent implements preliminary action by preventing ligand contamination at the source within the affinity column itself, rather than addressing contamination later in downstream processing. The second ligand is positioned to capture dissociated segments as they occur, eliminating the need for additional downstream separation steps and reducing both time and cost.
Solution Approach 2:
The patent extracts the contamination problem from the downstream processing stage and relocates it to the affinity column stage. By capturing leached ligands within the column using the second ligand, the system removes the harmful factor (contamination) at its origin, eliminating the need for subsequent extraction or removal steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively prevents contamination of purified species by capturing leached ligands, reducing downstream separation costs and time, while maintaining the purity of the final product by ensuring that only the intended solute is released from the affinity medium.
Implementation Method 1
the ligand being one to which the species of interest binds by an affinity-type interaction
Implementation Method 2
the second ligand is one that binds selectively to molecules of the first ligand or dissociated segments thereof that are not, or are no longer, immobilized on the support
Implementation Method 3
The ligand is typically a protein or other affinity-binding species that is coupled to a solid support by covalent bonds
Data Source
AI summary
In an affinity-type purification, ligands dissociated from the stationary phase that would otherwise leach into the species being purified are captured by a second ligand that is also incorporated into the stationary phase, the second ligand exhibiting an affinity-type interaction with the dissociated first ligand with sufficient specificity to avoid the undesired retention by the second ligand of species from the liquid sample or source liquid other than the species sought to be purified in the affinity column.